Waters Corporation
ACQUITY How-to-Series

Qualitative and Quantitative Characterization of a Glucosylceramide Inhibitor on Obesity

In this video poster from ASMS 2014, Robert Tonge of Waters presents a label-free, multi-omic study that qualitatively and quantitatively characterizes the effects of a glucosylceramide inhibitor on obesity.